Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M11,433Revenue $M7,435Net Margin (%)6.8Altman Z-Score2.9
Enterprise Value $M15,218EPS $3.8Operating Margin %13.3Piotroski F-Score5
P/E(ttm)22.7Beneish M-Score-2.7Pre-tax Margin (%)10.4Higher ROA y-yN
Price/Book2.710-y EBITDA Growth Rate %7.1Quick Ratio1.1Cash flow > EarningsY
Price/Sales1.55-y EBITDA Growth Rate %3.6Current Ratio1.1Lower Leverage y-yY
Price/Free Cash Flow19.0y-y EBITDA Growth Rate %-26.2ROA % (ttm)5.2Higher Current Ratio y-yN
Dividend Yield %1.7PEG6.4ROE % (ttm)12.3Less Shares Outstanding y-yN
Payout Ratio %39.0Shares Outstanding M144ROIC % (ttm)8.8Gross Margin Increase y-yN

Gurus Latest Trades with DGX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DGXRobert Olstein 2015-03-31 Sold Out -0.48%$66.27 - $77.69
($71.61)
$ 79.6011%Sold Out0
DGXBrian Rogers 2015-03-31 Reduce-0.3%$66.27 - $77.69
($71.61)
$ 79.6011%Reduce 41.67%1,750,000
DGXHOTCHKIS & WILEY 2015-03-31 Sold Out -0.23%$66.27 - $77.69
($71.61)
$ 79.6011%Sold Out0
DGXJohn Rogers 2015-03-31 Add0.11%$66.27 - $77.69
($71.61)
$ 79.6011%Add 33.49%515,958
DGXDavid Dreman 2015-03-31 Reduce-0.06%$66.27 - $77.69
($71.61)
$ 79.6011%Reduce 33.54%21,554
DGXChris Davis 2015-03-31 Reduce-0.02%$66.27 - $77.69
($71.61)
$ 79.6011%Reduce 1.68%5,068,925
DGXJoel Greenblatt 2015-03-31 Reduce-0.02%$66.27 - $77.69
($71.61)
$ 79.6011%Reduce 35.63%56,784
DGXCharles Brandes 2015-03-31 Reduce-0.01%$66.27 - $77.69
($71.61)
$ 79.6011%Reduce 6.12%174,714
DGXRobert Olstein 2014-12-31 Reduce-0.18%$57.71 - $68.1
($63.08)
$ 79.6026%Reduce 28.05%59,000
DGXCharles Brandes 2014-12-31 Buy 0.18%$57.71 - $68.1
($63.08)
$ 79.6026%New holding186,113
DGXRichard Pzena 2014-12-31 Sold Out -0.14%$57.71 - $68.1
($63.08)
$ 79.6026%Sold Out0
DGXHOTCHKIS & WILEY 2014-12-31 Reduce-0.13%$57.71 - $68.1
($63.08)
$ 79.6026%Reduce 38.25%983,900
DGXJoel Greenblatt 2014-12-31 Reduce-0.09%$57.71 - $68.1
($63.18)
$ 79.6026%Reduce 62.94%88,219
DGXHOTCHKIS & WILEY 2014-09-30 Reduce-0.19%$59.28 - $64.08
($61.73)
$ 79.6029%Reduce 36.86%1,593,262
DGXJoel Greenblatt 2014-09-30 Add0.14%$59.28 - $64.08
($61.73)
$ 79.6029%Add 5330.13%238,057
DGXChris Davis 2014-06-30 Add0.8%$55.5 - $61.75
($58.56)
$ 79.6036%Add 4465.97%4,672,681
DGXRichard Pzena 2014-06-30 Reduce-0.18%$55.5 - $61.75
($58.56)
$ 79.6036%Reduce 55.66%431,100
DGXRobert Olstein 2014-06-30 Reduce-0.14%$55.5 - $61.75
($58.56)
$ 79.6036%Reduce 18.00%82,000
DGXDavid Dreman 2014-06-30 Reduce-0.06%$55.5 - $61.75
($58.56)
$ 79.6036%Reduce 26.19%35,982
DGXJoel Greenblatt 2014-06-30 Reduce-0.06%$55.5 - $61.75
($58.56)
$ 79.6036%Reduce 94.26%4,384
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DGX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


DGX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PREVOZNIK MICHAEL ESVP & General Counsel 2015-03-03Sell3,261$71.1611.86view
PREVOZNIK MICHAEL ESVP & General Counsel 2015-02-17Sell488$71.4111.47view
GUINAN MARKSenior Vice President & CFO 2015-02-17Sell280$71.7410.96view
STANZIONE DANIELDirector 2015-02-11Sell8,000$70.9712.16view
PFEIFFER GARY MDirector 2015-02-04Sell8,000$72.439.9view
WILENSKY GAIL RDirector 2015-02-04Sell8,000$72.3410.04view
ZIEGLER JOHN BDirector 2015-02-03Sell8,000$71.8810.74view
BONGIORNO THOMAS FVP and Corporate Controller 2015-02-02Sell3,000$71.511.33view
BONGIORNO THOMAS FVP and Corporate Controller 2014-11-18Sell10,000$6424.38view
Cohen Jon RSVP and Chief Medical Officer 2014-11-17Sell160,029$63.1326.09view

Press Releases about DGX :

    Quarterly/Annual Reports about DGX:

    News about DGX:

    Articles On GuruFocus.com
    Vermillion (VRML) Ovarian Cancer Test Mega-deal; Papa Murphy's Holdings (FRSH) and Wix (WIX) Strong Mar 18 2015 
    Charles Brandes' Top Buys During Q4 Feb 11 2015 
    A Look at John Hussman's Recent Additions to His Portfolio Feb 06 2015 
    DGX: A Healthy Diagnosis Oct 08 2014 
    The Top Five Guru-Held Mid-Cap Stocks of Q2 Sep 04 2014 
    LabCorp: A Leading Independent Diagnostic Laboratory Aug 22 2014 
    Bernard Horn Comments on Quest Diagnostics Aug 07 2014 
    Top Five Guru-Owned Mid Cap Stocks Jun 18 2014 
    Morning Coffee: Widely Held Guru Stocks Trading Near Historical Low P/S May 28 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historic Low P/S May 13 2014 

    More From Other Websites
    Quest Diagnostics (DGX) Stock Higher After Takeover Tweet Caused Spike May 22 2015
    Quest chatter triggers huge profits May 22 2015
    Kunkle of OptionsHawk Says Quest Tweet Reflected Rumor May 22 2015
    Healthcare Providers ETF Calm After Quest Diagnostics Rumor May 22 2015
    Quest Diagnostics Spikes to Record on Tweeted M&A Speculation May 22 2015
    QUEST DIAGNOSTICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 18 2015
    Quest Diagnostics Declares Quarterly Cash Dividend May 15 2015
    Quest Diagnostics Declares Quarterly Cash Dividend May 15 2015
    Quest Diagnostics' QNatal Advanced for Prenatal Screening - Analyst Blog May 14 2015
    UMass Memorial seeks stake in Quest Diagnostics subsidiary May 13 2015
    Unicorns that earn billions by making real things May 13 2015
    Quest Diagnostics to Enhance Quality of Noninvasive Prenatal Screening with QNatal Advanced™ May 12 2015
    Quest Diagnostics to Enhance Quality of Noninvasive Prenatal Screening with QNatal Advanced™ May 12 2015
    Making Money With Charles Payne: 05/8/15 May 08 2015
    The Zacks Analyst Blog Highlights: Celgene, Laboratory Corp. of America Holdings, Quest Diagnostics... May 06 2015
    Quest Diagnostics Announces LeukoVantage™, Advancing Precision Medicine for Hematologic... May 04 2015
    Quest Diagnostics Announces LeukoVantage™, Advancing Precision Medicine for Hematologic... May 04 2015
    Sarissa Capital's biotech bets May 04 2015
    10-Q for Quest Diagnostics, Inc. May 03 2015
    QUEST DIAGNOSTICS INC Files SEC form 10-Q, Quarterly Report Apr 30 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK